TY - JOUR
T1 - Comparison of Adherence to the 2013 ACC/AHA Cholesterol Guideline in a Teaching Versus Nonteaching Outpatient Clinic
AU - Cheng-Lai, Angela
AU - Snead, Jessica
AU - Ng, Christina
AU - Verges, Caroline
AU - Chung, Philip
N1 - Publisher Copyright:
© 2017, © The Author(s) 2017.
PY - 2018/4/1
Y1 - 2018/4/1
N2 - Background: Little information is available regarding prescribers’ adherence rate to the 2013 American College of Cardiology (ACC)/American Heart Association (AHA) cholesterol guideline, especially that from a teaching versus a nonteaching setting. Objectives: We aim to evaluate adherence rates to the 2013 ACC/AHA cholesterol guideline in a teaching versus a nonteaching practice site. In addition, the impact of a pharmacist-led seminar on adherence rate to the guideline was assessed. Methods: This study is a 2-part retrospective chart review. Part 1 consists of patients who were initiated on statin therapy between December 2013 and November 2014. Patients were analyzed to determine if they received concordant statin therapy as recommended by the guideline. For the second part, we evaluated the impact of a seminar on the adherence rate to the guideline. Results: Of the 325 patients who received a statin prescription, 233 were included in the study. Prescriber adherence to the guideline was 42.9%, which was significantly lower than the 65.8% observed in a study previously conducted at a teaching outpatient clinic (P < 0.0001). For the second part of our study, prescriber adherence to the guideline 3 months before the pharmacist-led seminar was 53.5%, and this adherence rate remained virtually unchanged at 54.2% at 3 months after the educational session. Conclusion: The overall adherence rate to the 2013 ACC/AHA cholesterol guideline from this nonteaching outpatient clinic was significantly lower than that previously observed in a teaching outpatient clinic. The single pharmacist-led seminar did not significantly affect prescribers’ adherence rate to the guideline.
AB - Background: Little information is available regarding prescribers’ adherence rate to the 2013 American College of Cardiology (ACC)/American Heart Association (AHA) cholesterol guideline, especially that from a teaching versus a nonteaching setting. Objectives: We aim to evaluate adherence rates to the 2013 ACC/AHA cholesterol guideline in a teaching versus a nonteaching practice site. In addition, the impact of a pharmacist-led seminar on adherence rate to the guideline was assessed. Methods: This study is a 2-part retrospective chart review. Part 1 consists of patients who were initiated on statin therapy between December 2013 and November 2014. Patients were analyzed to determine if they received concordant statin therapy as recommended by the guideline. For the second part, we evaluated the impact of a seminar on the adherence rate to the guideline. Results: Of the 325 patients who received a statin prescription, 233 were included in the study. Prescriber adherence to the guideline was 42.9%, which was significantly lower than the 65.8% observed in a study previously conducted at a teaching outpatient clinic (P < 0.0001). For the second part of our study, prescriber adherence to the guideline 3 months before the pharmacist-led seminar was 53.5%, and this adherence rate remained virtually unchanged at 54.2% at 3 months after the educational session. Conclusion: The overall adherence rate to the 2013 ACC/AHA cholesterol guideline from this nonteaching outpatient clinic was significantly lower than that previously observed in a teaching outpatient clinic. The single pharmacist-led seminar did not significantly affect prescribers’ adherence rate to the guideline.
KW - HMG-CoA reductase inhibitors
KW - atherosclerotic cardiovascular disease
KW - cardiovascular drugs
KW - cholesterol
KW - clinical practice guidelines
KW - coronary heart disease
KW - evidence-based medicine
KW - guideline adherence
KW - hypercholesterolemia
KW - hyperlipidemia
KW - statins
UR - http://www.scopus.com/inward/record.url?scp=85042501114&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85042501114&partnerID=8YFLogxK
U2 - 10.1177/1060028017739325
DO - 10.1177/1060028017739325
M3 - Article
C2 - 29103310
AN - SCOPUS:85042501114
SN - 1060-0280
VL - 52
SP - 338
EP - 344
JO - Annals of Pharmacotherapy
JF - Annals of Pharmacotherapy
IS - 4
ER -